Prakash Gowd brings over 25 years of experience in biopharma and capital markets and is passionate about improving patient outcomes. His track record spans private and public companies, startups and large corporations, and different business models, healthcare verticals and emerging sectors. As a leader and strategist, he has held responsibility for people, P&Ls, financing, licensing, M&A, and go-public leadership.
Before joining TIAP, Prakash was Chief Operating Officer and Head of Corporate Development at a mental health and psychedelic medicine company where he played pivotal roles in building a network of clinics, bringing the company public, optimizing value of the U.S. operations, executing acquisitions, and managing the sale of the business. Previously, as Co-founder of a genetic testing company in medical cannabis, he worked collaboratively to assemble the team, develop and market the test, and eventually sell the company.
Prakash’s deep background in biopharma investment analysis was attained through a long tenure in equity research at large, reputable investment banks. The foundation of his career was built in commercial operations and new product development in the pharmaceutical industry.
Prakash holds an MBA from McGill University, undergraduate degrees in Pharmacy and Zoology from the University of British Columbia, and a Chartered Director designation. He is currently on the board of Appili Therapeutics.